Luis Escobar
About Luis Escobar
Luis Escobar serves as the Quality Assurance Manager at ElevateBio in Waltham, Massachusetts, where he has worked since 2022. He has a background in biology and extensive experience in quality assurance and supplier management within the biotechnology sector.
Work at ElevateBio
Luis Escobar has served as the Quality Assurance Manager at ElevateBio since 2022. In this role, he is responsible for overseeing quality assurance processes and ensuring compliance with industry standards. He developed and implemented a comprehensive Standard Operating Procedure (SOP) development program, which enhances operational efficiency and regulatory compliance within the organization. ElevateBio, located in Waltham, Massachusetts, focuses on advancing cell and gene therapies.
Education and Expertise
Luis Escobar earned a Bachelor's Degree in Biology from the University of Massachusetts Boston, studying from 2011 to 2015. His educational background provides a strong foundation for his expertise in quality assurance and risk assessment strategies, particularly within the biotechnology sector. He specializes in managing supplier relationships to ensure compliance with industry standards, which is crucial in maintaining product quality and safety.
Background
Luis Escobar has a diverse professional background in quality assurance and laboratory management. Before joining ElevateBio, he worked at Lyndra Therapeutics as a Quality Specialist and Quality Assurance Associate, where he contributed to quality management systems. His earlier roles include serving as a Laboratory Technician Group Lead at Miraca Life Sciences and as a Nationally Certified Pharmacy Technician at CVS Health. This varied experience has equipped him with a comprehensive understanding of quality processes in different settings.
Previous Experience
Prior to his current position, Luis Escobar held several roles that contributed to his expertise in quality assurance. He worked at Nova Biomedical as a Quality Control professional from 2017 to 2019 and at Lyndra Therapeutics in various capacities from 2019 to 2021. His experience also includes a role as a Research Assistant at the University of Massachusetts Boston in 2015. These positions have provided him with a broad range of skills applicable to the biotechnology field.